Literature DB >> 16714544

Macrophage migration inhibitory factor contributes to host defense against acute Trypanosoma cruzi infection.

José L Reyes1, Luis I Terrazas, Bertha Espinoza, David Cruz-Robles, Virgilia Soto, Irma Rivera-Montoya, Lorena Gómez-García, Heidi Snider, Abhay R Satoskar, Miriam Rodríguez-Sosa.   

Abstract

Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine that is involved in the host defense against several pathogens. Here we used MIF-/- mice to determine the role of endogenous MIF in the regulation of the host immune response against Trypanosoma cruzi infection. MIF-/- mice displayed high levels of blood and tissue parasitemia, developed severe heart and skeletal muscle immunopathology, and succumbed to T. cruzi infection faster than MIF+/+ mice. The enhanced susceptibility of MIF-/- mice to T. cruzi was associated with reduced levels of proinflammatory cytokines, such as tumor necrosis factor alpha, interleukin-12 (IL-12), IL-18, gamma interferon (IFN-gamma), and IL-1beta, in their sera and reduced production of IL-12, IFN-gamma, and IL-4 by spleen cells during the early phase of infection. At all time points, antigen-stimulated splenocytes from MIF+/+ and MIF-/- mice produced comparable levels of IL-10. MIF-/- mice also produced significantly less Th1-associated antigen-specific immunoglobulin G2a (IgG2a) throughout the infection, but both groups produced comparable levels of Th2-associated IgG1. Lastly, inflamed hearts from T. cruzi-infected MIF-/- mice expressed increased transcripts for IFN-gamma, but fewer for IL-12 p35, IL-12 p40, IL-23, and inducible nitric oxide synthase, compared to MIF+/+ mice. Taken together, our findings show that MIF plays a role in controlling acute T. cruzi infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16714544      PMCID: PMC1479264          DOI: 10.1128/IAI.01648-05

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  63 in total

1.  Pivotal role of interleukin-12 and interferon-gamma axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection.

Authors:  V Michailowsky; N M Silva; C D Rocha; L Q Vieira; J Lannes-Vieira; R T Gazzinelli
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

2.  Protection from septic shock by neutralization of macrophage migration inhibitory factor.

Authors:  T Calandra; B Echtenacher; D L Roy; J Pugin; C N Metz; L Hültner; D Heumann; D Männel; R Bucala; M P Glauser
Journal:  Nat Med       Date:  2000-02       Impact factor: 53.440

3.  Description of inflammation and cytokine profile at the inoculation site and in heart tissue of mice re-infected with Trypanosoma cruzi vector derived-metacyclic trypomastigotes.

Authors:  L Gómez-García; R Alejandre-Aguilar; A Aranda-Fraustro; R Lopez; V M Monteón
Journal:  Parasitology       Date:  2005-05       Impact factor: 3.234

4.  Migration-inhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection.

Authors:  A R Satoskar; M Bozza; M Rodriguez Sosa; G Lin; J R David
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

5.  Frequency of interferon- gamma -producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease.

Authors:  Susana A Laucella; Miriam Postan; Diana Martin; Bolyn Hubby Fralish; Maria C Albareda; Maria G Alvarez; Bruno Lococo; Gustavo Barbieri; Rodolfo J Viotti; Rick L Tarleton
Journal:  J Infect Dis       Date:  2004-02-17       Impact factor: 5.226

Review 6.  Induction of cell-mediated immunity during early stages of infection with intracellular protozoa.

Authors:  R T Gazzinelli; A Talvani; M M Camargo; H C Santiago; M A Oliveira; L Q Vieira; G A Martins; J C Aliberti; J S Silva
Journal:  Braz J Med Biol Res       Date:  1998-01       Impact factor: 2.590

7.  Macrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimurium.

Authors:  Heidrun Koebernick; Leander Grode; John R David; Wolfgang Rohde; Michael S Rolph; Hans-Willi Mittrücker; Stefan H E Kaufmann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-23       Impact factor: 11.205

8.  Macrophage migration inhibitory factor and host innate immune defenses against bacterial sepsis.

Authors:  Thierry Calandra; Céline Froidevaux; Christian Martin; Thierry Roger
Journal:  J Infect Dis       Date:  2003-06-15       Impact factor: 5.226

9.  The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor.

Authors:  T Calandra; J Bernhagen; R A Mitchell; R Bucala
Journal:  J Exp Med       Date:  1994-06-01       Impact factor: 14.307

10.  Real-time PCR based on SYBR-Green I fluorescence: an alternative to the TaqMan assay for a relative quantification of gene rearrangements, gene amplifications and micro gene deletions.

Authors:  Frederique Ponchel; Carmel Toomes; Kieran Bransfield; Fong T Leong; Susan H Douglas; Sarah L Field; Sandra M Bell; Valerie Combaret; Alain Puisieux; Alan J Mighell; Philip A Robinson; Chris F Inglehearn; John D Isaacs; Alex F Markham
Journal:  BMC Biotechnol       Date:  2003-10-13       Impact factor: 2.563

View more
  29 in total

1.  Macrophage migration inhibitory factor: a downregulator of early T cell-dependent IFN-gamma responses in Plasmodium chabaudi adami (556 KA)-infected mice.

Authors:  Diane Tshikudi Malu; Benoit Bélanger; François Desautels; Karine Kelendji; Esther Dalko; Jaime Sanchez-Dardon; Lin Leng; Richard Bucala; Abhay R Satoskar; Tatiana Scorza
Journal:  J Immunol       Date:  2011-04-25       Impact factor: 5.422

2.  Novel anti-inflammatory activity of epoxyazadiradione against macrophage migration inhibitory factor: inhibition of tautomerase and proinflammatory activities of macrophage migration inhibitory factor.

Authors:  Athar Alam; Saikat Haldar; Hirekodathakallu V Thulasiram; Rahul Kumar; Manish Goyal; Mohd Shameel Iqbal; Chinmay Pal; Sumanta Dey; Samik Bindu; Souvik Sarkar; Uttam Pal; Nakul C Maiti; Uday Bandyopadhyay
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

3.  Role of monocyte-acquired hemozoin in suppression of macrophage migration inhibitory factor in children with severe malarial anemia.

Authors:  Gordon A Awandare; Yamo Ouma; Collins Ouma; Tom Were; Richard Otieno; Christopher C Keller; Gregory C Davenport; James B Hittner; John Vulule; Robert Ferrell; John M Ong'echa; Douglas J Perkins
Journal:  Infect Immun       Date:  2006-10-23       Impact factor: 3.441

4.  Effect of macrophage migration inhibitory factor (MIF) in human placental explants infected with Toxoplasma gondii depends on gestational age.

Authors:  Angelica de Oliveira Gomes; Deise Aparecida de Oliveira Silva; Neide Maria Silva; Bellisa de Freitas Barbosa; Priscila Silva Franco; Mariana Bodini Angeloni; Marise Lopes Fermino; Maria Cristina Roque-Barreira; Nicoletta Bechi; Luana Ricci Paulesu; Maria Célia Dos Santos; José Roberto Mineo; Eloisa Amália Vieira Ferro
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

5.  MIF (macrophage migration inhibitory factor) promoter polymorphisms and susceptibility to severe malarial anemia.

Authors:  Gordon A Awandare; Jeremy J Martinson; Tom Were; Collins Ouma; Gregory C Davenport; John M Ong'echa; Wenkui Wang; Lin Leng; Robert E Ferrell; Richard Bucala; Douglas J Perkins
Journal:  J Infect Dis       Date:  2009-08-15       Impact factor: 5.226

6.  The unexpected role for the aryl hydrocarbon receptor on susceptibility to experimental toxoplasmosis.

Authors:  Yuriko Sanchez; Juan de Dios Rosado; Libia Vega; Guillermo Elizondo; Elizabeth Estrada-Muñiz; Rafael Saavedra; Imelda Juárez; Miriam Rodríguez-Sosa
Journal:  J Biomed Biotechnol       Date:  2010-01-11

7.  Macrophage migration inhibitory factor stimulates interleukin-17 expression and production in lymph node cells.

Authors:  Ivana Stojanović; Tamara Cvjetićanin; Sandra Lazaroski; Stanislava Stosić-Grujicić; Djordje Miljković
Journal:  Immunology       Date:  2008-06-20       Impact factor: 7.397

8.  Macrophage migration inhibitory factor (MIF) is critical for the host resistance against Toxoplasma gondii.

Authors:  Marcos Flores; Rafael Saavedra; Rocio Bautista; Rubi Viedma; Eda P Tenorio; Lin Leng; Yuriko Sánchez; Imelda Juárez; Anjali A Satoskar; Asha S Shenoy; Luis I Terrazas; Richard Bucala; Joseph Barbi; Abhay R Satoskar; Miriam Rodriguez-Sosa
Journal:  FASEB J       Date:  2008-07-07       Impact factor: 5.191

9.  Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion.

Authors:  Alvaro Arjona; Harald G Foellmer; Terrence Town; Lin Leng; Courtney McDonald; Tian Wang; Susan J Wong; Ruth R Montgomery; Erol Fikrig; Richard Bucala
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

10.  Elevated serum levels of macrophage migration inhibitory factor are associated with progressive chronic cardiomyopathy in patients with Chagas disease.

Authors:  Romina A Cutrullis; Patricia B Petray; Edgardo Schapachnik; Rubén Sánchez; Miriam Postan; Mariela N González; Valentina Martín; Ricardo S Corral
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.